The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Open accessAbstract
SUMMARY MicroRNAs are well-suited to regulate tumor metastasis due to their capacity to coordinately repress numerous target genes, thereby potentially enabling their intervention at multiple steps of the invasion-metastasis cascade. We identify a microRNA exemplifying these attributes, miR-31, whose expression correlates inversely with metastasis in human breast cancer patients. Overexpression of miR-31 in otherwise-aggressive breast tumor cells suppresses metastasis. We deploy a stable microRNA sponge strategy to stably inhibit miR-31 in vivo; this allows otherwise-non-aggressive breast cancer cells to metastasize. These phenotypes do not involve confounding influences on primary tumor development and are specifically attributable to miR-31-mediated inhibition of several steps of metastasis, including local invasion, extravasation or initial survival at a distant site, and metastatic colonization. Such pleiotropy is achieved via coordinate repression of a cohort of metastasis-promoting genes, including RhoA. Indeed, RhoA re-expression partially reverses miR-31-imposed metastasis-suppression. These findings indicate that miR-31 uses multiple mechanisms to oppose metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 4×
“invasion-metastasis cascade, which leads to these growths, is a complex, multistep process involving the escape of neoplastic cells from a primary tumor (local invasion), intravasation into the systemic circulation, survival during transit through the vasculature, extravasation into the parenchyma of distant tissues,…”
InfluentialCombinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Cited by
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Self-citationThe multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Self-citationLujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
Self-citationMicroRNA sponges: Progress and possibilities
Ebert, M. S., & Sharp, P. A. (2010) · RNA · doi:10.1261/rna.2414110 · Cited by 762
“…the transgene from chromosomal integrations (Scherr et al. 2007; Bonci et al. 2008; Gentner et al. 2009; Haraguchi et al. 2009; Huang et al. 2010; Valastyan et al. 2009; Barbato et al. 2010; Gatt et al. 2010; Gottwein and Cullen 2010; Ma et al. 2010a,b; Papapetrou et al. 2010; Starczynowski et…”
InfluentialTumor metastasis: moving new biological insights into the clinic
Wan, L., Pantel, K., & Kang, Y. (2013) · Nature Medicine · doi:10.1038/nm.3391 · Cited by 748
miR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
Vanharanta, S., & Massagué, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.007 · Cited by 563
Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
Venet, D., Dumont, J. E., & Detours, V. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002240 · Cited by 586
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Pigati, L., Yaddanapudi, S. C. S., Iyengar, R., Kim, D.-J., Hearn, S. A., Danforth, D., Hastings, M. L., & Duelli, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013515 · Cited by 582
Emerging Roles for Natural MicroRNA Sponges
Ebert, M. S., & Sharp, P. A. (2010) · Current Biology · doi:10.1016/j.cub.2010.08.052 · Cited by 483
MicroRNAs and their target gene networks in breast cancer
O'Day, E., & Lal, A. (2010) · Breast Cancer Research · doi:10.1186/bcr2484 · Cited by 439
Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H.-K., Hung, M.-C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2940 · Cited by 413
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C. B., & Liu, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013735 · Cited by 398
WBSMDA: Within and Between Score for MiRNA-Disease Association prediction
Chen, X., Yan, C. C., Zhang, X., You, Z.-H., Deng, L., Liu, Y., Zhang, Y., & Dai, Q. (2016) · Scientific Reports · doi:10.1038/srep21106 · Cited by 376
Chou, J., Lin, J. H., Brenot, A., Kim, J.-W., Provot, S., & Werb, Z. (2013) · Nature Cell Biology · doi:10.1038/ncb2672 · Cited by 373
Liu, X., Sempere, L. F., Ouyang, H., Memoli, V. A., Andrew, A. S., Luo, Y., Demidenko, E., Korc, M., Shi, W., Preis, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39566 · Cited by 373
Augoff, K., McCue, B., Plow, E. F., & Sossey-Alaoui, K. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-5 · Cited by 363
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
ALLEGRA, A., ALONCI, A., CAMPO, S., PENNA, G., PETRUNGARO, A., GERACE, D., & MUSOLINO, C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1647 · Cited by 359
The nuclear envelope environment and its cancer connections
Chow, K.-H., Factor, R. E., & Ullman, K. S. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3219 · Cited by 359
MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Farazi, T. A., Horlings, H. M., ten Hoeve, J. J., Mihailovic, A., Halfwerk, H., Morozov, P., Brown, M., Hafner, M., Reyal, F., van Kouwenhove, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0608 · Cited by 346
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
MicroRNAs in apoptosis, autophagy and necroptosis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.3523 · Cited by 342
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
Brown, B. D., & Naldini, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2628 · Cited by 336
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 334
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 331
Yamagishi, M., Nakano, K., Miyake, A., Yamochi, T., Kagami, Y., Tsutsumi, A., Matsuda, Y., Sato-Otsubo, A., Muto, S., Utsunomiya, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.015 · Cited by 329
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
McGuire, A., Brown, J. A. L., & Kerin, M. J. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9551-7 · Cited by 329
miRNA control of tumor cell invasion and metastasis
Baranwal, S., & Alahari, S. K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25014 · Cited by 316
A MicroRNA Expression Signature for Cervical Cancer Prognosis
Hu, X., Schwarz, J. K., Lewis, J. S., Huettner, P. C., Rader, J. S., Deasy, J. O., Grigsby, P. W., & Wang, X. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3289 · Cited by 310
Fang, J.-H., Zhou, H.-C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J.-P., Guan, X.-Y., & Zhuang, S.-M. (2011) · Hepatology · doi:10.1002/hep.24577 · Cited by 307
GATA3 in development and cancer differentiation: Cells GATA have it!
Chou, J., Provot, S., & Werb, Z. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21943 · Cited by 304
Liu, C.-J., Tsai, M.-M., Hung, P.-S., Kao, S.-Y., Liu, T.-Y., Wu, K.-J., Chiou, S.-H., Lin, S.-C., & Chang, K.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2291 · Cited by 303
Diabetes mellitus, a microRNA-related disease?
Guay, C., Roggli, E., Nesca, V., Jacovetti, C., & Regazzi, R. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.009 · Cited by 300
Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
Hurst, D. R., Edmonds, M. D., & Welch, D. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2111 · Cited by 299
van Schooneveld, E., Wildiers, H., Vergote, I., Vermeulen, P. B., Dirix, L. Y., & Van Laere, S. J. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0526-y · Cited by 296
Control of metastatic progression by microRNA regulatory networks
Pencheva, N., & Tavazoie, S. F. (2013) · Nature Cell Biology · doi:10.1038/ncb2769 · Cited by 295
Wong, C. C., Wong, C., Tung, E. K., Au, S. L., Lee, J. M., Poon, R. T., Man, K., & Ng, I. O. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.006 · Cited by 295
microRNAs in Early Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats
Kovacs, B., Lumayag, S., Cowan, C., & Xu, S. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6879 · Cited by 293
The Molecular Balancing Act of p16INK4a in Cancer and Aging
LaPak, K. M., & Burd, C. E. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0350 · Cited by 291
microRNAs: Master Regulators as Potential Therapeutics in Cancer
Garofalo, M., & Croce, C. M. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100517 · Cited by 291
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
Osaki, M., Takeshita, F., Sugimoto, Y., Kosaka, N., Yamamoto, Y., Yoshioka, Y., Kobayashi, E., Yamada, T., Kawai, A., Inoue, T., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.53 · Cited by 271
Zheng, B., Liang, L., Wang, C., Huang, S., Cao, X., Zha, R., Liu, L., Jia, D., Tian, Q., Wu, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1714 · Cited by 269
Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer
Liu, C.-J., Kao, S.-Y., Tu, H.-F., Tsai, M.-M., Chang, K.-W., & Lin, S.-C. (2010) · Oral Diseases · doi:10.1111/j.1601-0825.2009.01646.x · Cited by 268
miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells
Cottonham, C. L., Kaneko, S., & Xu, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160069 · Cited by 265
Creighton, C. J., Fountain, M. D., Yu, Z., Nagaraja, A. K., Zhu, H., Khan, M., Olokpa, E., Zariff, A., Gunaratne, P. H., Matzuk, M. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3875 · Cited by 264
Role of microRNAs in diabetes and its cardiovascular complications
Shantikumar, S., Caporali, A., & Emanueli, C. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr300 · Cited by 263
GAMBARI, R., BROGNARA, E., SPANDIDOS, D. A., & FABBRI, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3503 · Cited by 262
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella‐Abate, S., De Pittà, C., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.102 · Cited by 261
MicroRNA-21 Regulates Astrocytic Response Following Spinal Cord Injury
Bhalala, O. G., Pan, L., Sahni, V., McGuire, T. L., Gruner, K., Tourtellotte, W. G., & Kessler, J. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3860-12.2012 · Cited by 220
“This type of miRNA inhibition has been used successfully in vitro as well as in vivo to study the function of other miRNAs (Valastyan et al., 2009; Ma et al., 2010; Dey et al., 2011; Luikart et al., 2011; Åkerblom et al., 2012), although to the best of our knowledge, we have generated the first…”
MethodDeciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis
Chan, C.-H., Lee, S.-W., Li, C.-F., Wang, J., Yang, W.-L., Wu, C.-Y., Wu, J., Nakayama, K. I., Kang, H.-Y., Huang, H.-Y., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2047 · Cited by 209
miR-132 Mediates the Integration of Newborn Neurons into the Adult Dentate Gyrus
Luikart, B. W., Bensen, A. L., Washburn, E. K., Perederiy, J. V., Su, K. G., Li, Y., Kernie, S. G., Parada, L. F., & Westbrook, G. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019077 · Cited by 160
miR-139-5p is a regulator of metastatic pathways in breast cancer
Krishnan, K., Steptoe, A. L., Martin, H. C., Pattabiraman, D. R., Nones, K., Waddell, N., Mariasegaram, M., Simpson, P. T., Lakhani, S. R., Vlassov, A., et al. (2013) · RNA · doi:10.1261/rna.042143.113 · Cited by 134
MicroRNA as an Important Target for Anticancer Drug Development
Fu, Z., Wang, L., Li, S., Chen, F., Au-Yeung, K. K.-W., & Shi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.736323 · Cited by 133
The Roles of MicroRNAs in Breast Cancer
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2015) · Cancers · doi:10.3390/cancers7020598 · Cited by 116
Böhlig, L., Friedrich, M., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq796 · Cited by 85
MiR‐483–5p suppresses the proliferation of glioma cells via directly targeting ERK1
Wang, L., Shi, M., Hou, S., Ding, B., Liu, L., Ji, X., Zhang, J., & Deng, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.035 · Cited by 87
miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer
ZHANG, W.-L., LV, W., SUN, S.-Z., WU, X.-Z., & ZHANG, J.-H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2993 · Cited by 75
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
Cheng, H. S., Njock, M.-S., Khyzha, N., Dang, L. T., & Fish, J. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00422 · Cited by 69
Mousavi, T., & Abdollahi, M. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00332-1 · Cited by 57
Control by a hair’s breadth: the role of microRNAs in the skin
Ning, M. S., & Andl, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1117-z · Cited by 48
“On one hand, miR-31 is associated with progrowth and anti-metastatic properties in breast cancer [45]; on the other hand, it is regarded as a tumor suppressor in mesothelioma [46].”
Han, F., Huang, D., Huang, X., Wang, W., Yang, S., & Chen, S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15402 · Cited by 42
(2012) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Metadata
- Authors
- Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., & Weinberg, R. A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 137
- Issue
- 6
- Pages
- 1032-1046
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1978944350
- Cited by
- 820
- References
- 40
- FWCI
- 31.47
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.